Posts by Sandra Ansanay-Alex
Novigenix AI Spin-Out to Accelerate AI-Powered Immune Intelligence
Novigenix SA, a Swiss Health Valley leader in immunotranscriptomic diagnostics, announced the formal spin-out and launch of Novigenix AI, a new precision medicine company dedicated to transforming therapy development through AI-powered immune intelligence. A Strategic Separation to Unlock Two High-Growth Markets The new AI spin-out separates Novigenix’s colorectal cancer (CRC) screening business from its rapidly…
Read MoreHUG Launch a Women’s Cardiovascular Health Center
The Hôpitaux universitaires de Genève (HUG) announce the creation of a new Women’s Cardiovascular Health Center, a dedicated initiative designed to improve the diagnosis, prevention, and treatment of cardiovascular diseases in women. Cardiovascular diseases remain the leading cause of death in Switzerland, accounting for approximately 20,000 deaths each year, according to the Federal Office of…
Read MoreAlithea Genomics Closes CHF 6.9 M Seed Round
The Biopôle-based emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced the closing of its seed financing round with an additional CHF 3 million ($3.9 million), led by Genku Ventures and joined by Novalis Biotech and Zürcher Kantonalbank as well as several private investors. This additional funding brings the total seed round…
Read MoreXsensio SA Raises $7 Million in Oversubscribed Series A Funding
Xsensio SA, a Vaud-based high-tech company pioneering continuous biochemical monitoring in near real time, announced the closing of a Series A funding round with an oversubscription of $7 million. The round was led by San Francisco-based venture capital firm WI Harper, with participation from Privilège Ventures, the European Innovation Council and private investors from the…
Read MoreClee Medical Secures Seed Funding to Advance Real-Time Brain Imaging Technology
Clee Medical, a Geneva-based neurotechnology startup, has successfully closed its Seed financing round to accelerate the development of its ultra-high-resolution real-time imaging platform for brain surgery. The round was led by High-Tech Gründerfonds (HTGF), with participation from Zürcher Kantonalbank (ZKB), Kickfund, FONGIT, Venture Kick, and continued support from Wyss Geneva. At the core of the…
Read MoreKYLYS AESTHETICS SA Completes its First Clinical Trial
KYLYS AESTHETICS SA, a University of Geneva spinoff and Swiss clinical-stage biotech company developing next-generation regenerative aesthetic medical devices, announces the successful completion of patient injections in its first clinical trial. A total of 55 patients have now been treated as part of this study evaluating the company’s proprietary hyaluronic acid-based injectable technology. This milestone…
Read MoreSeprify and Grolman Launch SilvaLuma™ in Cosmetics Market
The Fribourg-based company created a cellulose-based ingredient, SilvaLuma™ as an alternative to titanium dioxide for coloring food or cosmetic products.
Read MoreScience Corp. and Neurosoft Bioelectronics Announce Novel BCI Ecosystem Partnership
Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft Bioelectronics, a Swiss neural data company utilizing ultra-soft interfaces to achieve full- cortical coverage powering a foundational AI model of the brain, have partnered to grant Neurosoft access to Science’s full stack of world-class clinical-grade neural recording tools, known…
Read MoreCarewell Gets a FIT Digital Growth Loan
Carewell, the Vaud-based digital platform for managing replacement healthcare staff, has been granted a CHF 200,000 Digital Growth Loan from Fondation pour l’Innovation Technologique (FIT). The staff shortage in Switzerland is set to worsen, with an expected shortfall of 40,000 people by 2040. Part of the problem is the process of managing replacement staff. Until…
Read MoreNose Switzerland Gets a FIF Seed Impact Grant
Nose Switzerland is addressing malnutrition in cancer patients with taste and smell disorders. The project got a CHF 20,000 FIF Seed Impact Grant. Developed in close collaboration with researchers from Hôpitaux Universitaires de Genève (HUG) and Université de Genève (UNIGE), Nose Switzerland addresses a pressing but often overlooked consequence of cancer treatment: chemosensory dysfunction. Patients who undergo…
Read More